AWM
PFE icon

Aberdeen Wealth Management’s Pfizer PFE Stock Holding History

Aberdeen Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$291K Sell
12,072
-1,051
-8% -$27.5K 0.14% 101
2026
Q1 		$368K Buy
13,123
+2
+0% +$53 0.17% 107
2025
Q4 		$327K Sell
13,121
-1,079
-8% -$27.2K 0.15% 115
2025
Q3 		$362K Sell
14,200
-222
-2% -$5.48K 0.23% 105
2025
Q2 		$350K Sell
14,422
-583
-4% -$13.6K 0.23% 107
2025
Q1 		$380K Sell
15,005
-398
-3% -$10.4K 0.26% 98
2024
Q4 		$409K Sell
15,403
-4,899
-24% -$133K 0.28% 97
2024
Q3 		$588K Buy
20,302
+476
+2% +$13.9K 0.39% 79
2024
Q2 		$555K Sell
19,826
-1,149
-5% -$31.6K 0.38% 77
2024
Q1 		$582K Sell
20,975
-1,726
-8% -$47.9K 0.34% 78
2023
Q4 		$654K Sell
22,701
-291
-1% -$8.8K 0.47% 64
2023
Q3 		$763K Buy
22,992
+1
+0% +$35 0.57% 46
2023
Q2 		$843K Buy
22,991
+1
+0% +$39 0.61% 42
2023
Q1 		$938K Sell
22,990
-4,574
-17% -$198K 0.7% 40
2022
Q4 		$1.41M Buy
27,564
+4,576
+20% +$219K 1.07% 25
2022
Q3 		$1.01M Sell
22,988
-59
-0.3% -$2.87K 0.89% 35
2022
Q2 		$1.21M Sell
23,047
-135
-0.6% -$6.88K 0.96% 30
2022
Q1 		$1.2M Buy
23,182
+300
+1% +$15.6K 0.82% 34
2021
Q4 		$1.35M Buy
22,882
+488
+2% +$24.2K 0.88% 29
2021
Q3 		$963K Sell
22,394
-766
-3% -$33.9K 0.93% 33
2021
Q2 		$907K Hold
23,160
– – 0.84% 39
2021
Q1 		$839K Sell
23,160
-389
-2% -$13.8K 0.67% 46
2020
Q4 		$867K Sell
23,549
-71
-0.3% -$2.6K 0.65% 40
2020
Q3 		$822K Sell
23,620
-348
-1% -$12.2K 0.78% 37
2020
Q2 		$744K Buy
23,968
+4,074
+20% +$138K 0.8% 40
2020
Q1 		$616K Sell
19,894
-462
-2% -$15.7K 0.75% 44
2019
Q4 		$757K Buy
+20,356
New +$725K 0.56% 47

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Aberdeen Wealth Management's PFE Position: Q2 2026 in Review

Aberdeen Wealth Management reduced its Pfizer (PFE) stake by 8% in Q2 2026, selling an estimated $27.5K and leaving 12,072 shares worth $291K. The position accounts for 0.14% of the portfolio, ranked #101.

Aberdeen Wealth Management first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.41M in Q4 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Aberdeen Wealth Management held 12,072 shares of Pfizer worth $291K as of Q2 2026.
  • Aberdeen Wealth Management sold 1,051 Pfizer shares in Q2 2026, an estimated $27.5K.
  • Pfizer made up 0.14% of Aberdeen Wealth Management's portfolio in Q2 2026, its #101 holding.
  • Aberdeen Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Aberdeen Wealth Management's Pfizer position peaked at $1.41M in Q4 2022.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Aberdeen Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.